LRI Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

LRI Investments’s Portfolio BIO Stock Details BIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$587	Sell	2 -34	-94%	-$9.64K	﹤0.01%	1503
2026 Q1	$10K	Buy	36 +22	+157%	+$6.34K	﹤0.01%	884
2025 Q4	$4.24K	Hold	14	–	–	﹤0.01%	1078
2025 Q3	$3.93K	Hold	14	–	–	﹤0.01%	1091
2025 Q2	$3.38K	Buy	14 +10	+250%	+$2.36K	﹤0.01%	1094
2025 Q1	$974	Buy	+4	New	+$1.2K	﹤0.01%	1156
2024 Q3	–	Sell	-9	Closed	-$2.46K	–	1155
2024 Q2	$2.46K	Hold	9	–	–	﹤0.01%	1026
2024 Q1	$3.11K	Buy	+9	New	+$2.96K	﹤0.01%	695

Other funds holding BIO

Assenagon Asset Management

Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return

Handelsbanken Fonder

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Beacon Investment Advisory Services Morristown, New Jersey $2.69B AUM 35.07% 1-Year Est. Return

Financial Management Professionals Austin, Texas $1.05B AUM 21.07% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Wolff Wiese Magana Carslbad, California $217M AUM 47.64% 1-Year Est. Return